logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yasushi Tsuji

department of medical oncology
H指数:33
被引数:4,364

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A multicenter retrospective study on the clinical features of patients with human epidermal growth factor receptor 2-positive colorectal cancer (HGCSG2304)

多中心回顾性研究探讨人表皮生长因子受体2阳性结直肠癌患者的临床特征（HGCSG2304）

International Journal of Clinical Oncology
IF2.8
2026-09-050
PRE
Shiho Kaneko; Kentaro Sawada; Kazuteru Hatanaka; Masayoshi Dazai; Hiroshi Nakatsumi; Takayuki Ando; Masahito Kotaka; Yasushi Tsuji; Michio Nakamura; Osamu Muto; Takashi Meguro; Takahiro Ishii; Atsushi Sato; Susumu Sogabe; Shintaro Sawaguchi; Tatsuya Yokoyama; Koichi Ishida; Kazuaki Harada; Yasuyuki Kawamoto; Satoshi Yuki; Naoya Sakamoto; Yu Sakata; Yoshito Komatsu
Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B)

阿贝西利在激素受体阳性、HER2阴性转移性乳腺癌患者中，在阿贝西利联合内分泌治疗进展后的再次挑战：来自II期again研究（WJOG14220B）的结果

Breast Cancer Research and Treatment
IF3
2026-07-200
OA
Meiko Nishimura; Takahiro Kogawa; Keiji Sugiyama; Yukinori Ozaki; Yuko Tanabe; Chikako Funasaka; Sasagu Kurozumi; Akiyo Yoshimura; Tsutomu Iwasa; Hitomi Sakai; Mitsunori Morita; Satomi Watanabe; Takaaki Fujii; Mitsugu Yamamoto; Yasushi Tsuji; Mitsuo Terada; Takayo Ota; Shinya Tokunaga; Mototsugu Shimokawa; Toshimi Takano
Efficacy and safety of trastuzumab biosimilar CT-P6 plus SOX or CapeOX in HER2-positive advanced gastric cancer: a multicenter phase II KSCC-TROX study

曲妥珠单抗生物类似物CT-P6联合SOX或CapeOX在HER2阳性晚期胃癌中的疗效和安全性：一项多中心II期KSCC-TROX研究

Gastric Cancer
IF5.1
2026-03-010
PRE
Oki, Eiji; Yamada, Teppei; Kashiwada, Tomomi; Sonoda, Hideto; Kataoka, Masato; Kawanaka, Hirofumi; Tsuji, Yasushi; Makiyama, Akitaka; Ota, Mitsuhiko; Hu, Qingjiang; Ando, Koji; Tsuda, Yasuo; Shimokawa, Mototsugu; Yoshizumi, Tomoharu
Seven-year survival with no recurrence after conversion surgery for pancreatic ductal adenocarcinoma with peritoneal metastasis treated with intraperitoneal and intravenous chemotherapy: A case report

胰腺导管腺癌合并腹膜转移患者行腹膜内及静脉化疗后，在转化手术后获得7年无复发生存：1例病例报告

MOLECULAR AND CLINICAL ONCOLOGY
IF1.4
2025-12-010
PRE
Takahashi, Mamoru; Matsumoto, Joe; Suzuki, Yoshinori; Oyamada, Yumiko; Tsuji, Yasushi; Hirano, Satoshi
ONO-4578 Plus Nivolumab in Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer

ONO-4578 Plus Nivolumab治疗不可切除的局部晚期或复发性胃或胃食管结合部癌

Cancer Science
IF4.3
2025-07-060
OAAI
Akihito Kawazoe; Kensei Yamaguchi; Tetsuya Hamaguchi; Yukiya Narita; Shogen Boku; Takashi Oshima; Hiroki Hara; Yasuo Hamamoto; Kenji Ishido; Taito Esaki; Hisashi Hosaka; Hirofumi Yasui; Keisuke Koeda; Tomohiro Nishina; Yasushi Tsuji; Takeo Fukagawa; Masahiro Goto; Eiji Oki; Naotoshi Sugimoto; Hiroshi Matsuoka; Fumiharu Yokoyama; Tomoko Yoshida; Kazuo Yoshida; Yoshiaki Oshima; Satoru Iwasa
A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018G
TARGETED ONCOLOGY
IF4
2024-03-010
OAAI
Matsumoto, Toshihiko; Yamamoto, Yoshiyuki; Kotaka, Masahito; Masuishi, Toshiki; Tsuji, Yasushi; Shoji, Hirokazu; Hirata, Kenro; Tsuduki, Takao; Makiyama, Akitaka; Izawa, Naoki; Takahashi, Naoki; Tsuda, Masahiro; Yasui, Hisateru; Ohta, Takashi; Kito, Yosuke; Otsu, Satoshi; Hironaka, Shuichi; Yamazaki, Kentaro; Boku, Narikazu; Hyodo, Ichinosuke; Yoshimura, Kenichi; Muro, Kei
Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer

在TRUSTY研究中使用血浆血管生成相关因子和无细胞DNA进行探索性生物标志物分析: 一项关于三氟尿苷/替匹拉西加贝伐单抗作为转移性结直肠癌二线治疗的随机II/III期研究

TARGETED ONCOLOGY
IF4
2024-01-094
OAAI
Sunakawa, Yu; Kuboki, Yasutoshi; Watanabe, Jun; Terazawa, Tetsuji; Kawakami, Hisato; Yokota, Mitsuru; Nakamura, Masato; Kotaka, Masahito; Sugimoto, Naotoshi; Ojima, Hitoshi; Oki, Eiji; Kajiwara, Takeshi; Yamamoto, Yoshiyuki; Tsuji, Yasushi; Denda, Tadamichi; Tamura, Takao; Ishihara, Soichiro; Taniguchi, Hiroya; Nakajima, Takako Eguchi; Morita, Satoshi; Shirao, Kuniaki; Takenaka, Naruhito; Ozawa, Daisuke; Yoshino, Takayuki
Phase II Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 and Cisplatin for Gastric Cancer with Peritoneal Metastasis
ANNALS OF SURGICAL ONCOLOGY
IF3.5
2023-11-1111
PRE
Kobayashi, Daisuke; Kodera, Yasuhiro; Fukushima, Ryoji; Morita, Masaru; Fushida, Sachio; Yamashita, Naoyuki; Yoshikawa, Kozo; Ueda, Shugo; Yabusaki, Hiroshi; Kusumoto, Tetsuya; Arigami, Takaaki; Hidemura, Akio; Omori, Takeshi; Yamaguchi, Hironori; Hirono, Yasuo; Tsuji, Yasushi; Moon, Jeong Ho; Tomita, Toshihiko; Imamura, Hiroshi; Nakanishi, Koki; Shimizu, Dai; Hirakawa, Akihiro; Ishigami, Hironori; Kitayama, Joji
ASO Visual Abstract: Phase II Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 and Cisplatin for Gastric Cancer with Peritoneal Metastasis
ANNALS OF SURGICAL ONCOLOGY
IF3.5
2023-11-100
PRE
Kobayashi, Daisuke; Kodera, Yasuhiro; Fukushima, Ryoji; Morita, Masaru; Fushida, Sachio; Yamashita, Naoyuki; Yoshikawa, Kozo; Ueda, Shugo; Yabusaki, Hiroshi; Kusumoto, Tetsuya; Arigami, Takaaki; Hidemura, Akio; Omori, Takeshi; Yamaguchi, Hironori; Hirono, Yasuo; Tsuji, Yasushi; Moon, Jeong Ho; Tomita, Toshihiko; Imamura, Hiroshi; Nakanishi, Koki; Shimizu, Dai; Hirakawa, Akihiro; Ishigami, Hironori; Kitayama, Joji
Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised study
EJNMMI RESEARCH
IF3
2023-07-171
OAAI
Takeuchi, Satoshi; Hirata, Kenji; Magota, Keiichi; Watanabe, Shiro; Moku, Rika; Shiiya, Akihiko; Taguchi, Jun; Ariga, Shin; Goda, Tomohiro; Ohhara, Yoshihito; Noguchi, Takurou; Shimizu, Yasushi; Kinoshita, Ichiro; Honma, Rio; Tsuji, Yasushi; Homma, Akihiro; Dosaka-Akita, Hirotoshi
Study protocol for HGCSG1801: A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibodies
FRONTIERS IN ONCOLOGY
IF3.3
2022-11-091
OAAI
Nakatsumi, Hiroshi; Komatsu, Yoshito; Muranaka, Tetsuhito; Yuki, Satoshi; Kawamoto, Yasuyuki; Harada, Kazuaki; Dazai, Masayoshi; Tateyama, Miki; Sasaki, Yusuke; Miyagishima, Takuto; Tsuji, Yasushi; Katagiri, Masaki; Nakamura, Michio; Sogabe, Susumu; Hatanaka, Kazuteru; Meguro, Takashi; Kobayashi, Tomoe; Ishiguro, Atsushi; Muto, Osamu; Shindo, Yoshiaki; Kotaka, Masahito; Ando, Takayuki; Takagi, Ryo; Sakamoto, Naoya; Sakata, Yu
Synopsis of a clinical practice guideline for pancreatic ductal adenocarcinoma with peritoneal dissemination in Japan; Japan Peritoneal Malignancy Study Group
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
IF2.8
2022-01-0714
OA
Satoi, Sohei; Takahara, Naminatsu; Fujii, Tsutomu; Isayama, Hiroyuki; Yamada, Suguru; Tsuji, Yasushi; Miyato, Hideyo; Yamaguchi, Hironori; Yamamoto, Tomohisa; Hashimoto, Daisuke; Yamaki, So; Nakai, Yousuke; Saito, Kei; Baba, Hayato; Watanabe, Toru; Ishii, Shigeto; Hayashi, Masamichi; Kurimoto, Keisuke; Shimada, Hideaki; Kitayama, Joji
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer

含贝伐单抗的一线化疗治疗转移性结直肠癌患者早期疾病进展后的二线化疗

BMC CANCER
IF3.4
2021-10-293
OAAI
Yamamoto, Shun; Nagashima, Kengo; Kawakami, Takeshi; Mitani, Seiichiro; Komoda, Masato; Tsuji, Yasushi; Izawa, Naoki; Kawakami, Kentaro; Yamamoto, Yoshiyuki; Makiyama, Akitaka; Yamazaki, Kentaro; Masuishi, Toshiki; Esaki, Taito; Nakajima, Takako Eguchi; Okuda, Hiroyuki; Moriwaki, Toshikazu; Boku, Narikazu
HGCSG 1603: A phase 2 trial of ramucirumab plus irinotecan as second-line treatment for advanced gastric cancer
ANNALS OF ONCOLOGY
IF65.4
2021-07-010
PREAI
Sawada, Kentaro; Kawamoto, Yasuyuki; Yuki, Satoshi; Nakamura, Michio; Muto, Osamu; Sogabe, Susumu; Shindo, Ysohiaki; Ishiguro, Atsushi; Sato, Atsushi; Tsuji, Yasushi; Dazai, Masayoshi; Okuda, Hiroyuki; Sasaki, Takahide; Harada, Kazuaki; Nakano, Shintaro; Nakatsumi, Hiroshi; Sekiguchi, Mari; Sakata, Yuh; Sakamoto, Naoya; Komatsu, Yoshito
HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of second-line treatment
ANNALS OF ONCOLOGY
IF65.4
2021-07-010
OAAI
Kaneko, S.; Ito, K.; Yuki, S.; Harada, K.; Yagisawa, M.; Sawada, K.; Ishiguro, A.; Muto, O.; Hatanaka, K.; Okuda, H.; Sato, A.; Sasaki, Y.; Nakamura, M.; Sasaki, T.; Tsuji, Y.; Ando, T.; Kato, K.; Wakabayashi, T.; Kotaka, M.; Takahashi, Y.; Sakata, Y.; Komatsu, Y.

研究方向

暂未获取到该数据
Y
Yoshito Komatsu
H 指数:54论文数:829被引数:1.5万
S
Satoshi Yuki
H 指数:24论文数:460被引数:2,262
H
Hiroyuki Okuda
H 指数:26论文数:258被引数:2,544
M
Michio Nakamura
H 指数:32论文数:264被引数:3,787
K
Kazuteru Hatanaka
H 指数:13论文数:200被引数:614
K
Kazuaki Harada
H 指数:9论文数:155被引数:253
K
Kensei Yamaguchi
H 指数:65论文数:921被引数:2.1万
K
Kei Muro
H 指数:80论文数:1,040被引数:4.3万
T
Tadamichi Denda
H 指数:29论文数:272被引数:3,396
Y
Yasuyuki Kawamoto
H 指数:18论文数:218被引数:1,885